Levodopa and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Levodopa and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levodopa
Brand name: Inbrija, Dopar, Larodopa
Synonyms: Levodopa (Oral)
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Levodopa-Pneumococcal 13-valent conjugate vaccine
- Levodopa-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Levodopa-Pneumococcal Conjugate Vaccine (13-Valent)
- Levodopa-Pneumococcal Conjugate Vaccine (7-Valent)
- Levodopa-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Levodopa-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Levodopa (Oral Inhalation)
- Pms-Sodium Polystyrene Sulfonate-Levodopa inhalation
- Pms-Sodium Polystyrene Sulfonate-Levodopa, Carbidopa, and Entacapone
- Pms-Sodium Polystyrene Sulfonate-Levodopa/Carbidopa
- Pms-Sodium Polystyrene Sulfonate-Levofloxacin
- Pms-Sodium Polystyrene Sulfonate-Levofloxacin (Systemic)